Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High in Vitro Therapeutic Index
Vancomycin is a glycopeptide antibiotic that inhibits transpeptidation during cell wall synthesis by binding to the D-Ala-D-Ala termini of lipid II. For long, it has been used as a last resort antibiotic. However, since the emergence of the first vancomycin-resistant enterococci in 1987, vancomycin...
Main Authors: | Nigam M. Mishra, Izabela Stolarzewicz, David Cannaerts, Joris Schuermans, Rob Lavigne, Yannick Looz, Bart Landuyt, Liliane Schoofs, Dominique Schols, Jan Paeshuyse, Peter Hickenbotham, Martha Clokie, Walter Luyten, Erik V. Van der Eycken, Yves Briers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01175/full |
Similar Items
-
Influence of a subinhibitory concentration of vancomycin on the in vitro expression of virulence-related genes in the vancomycin-resistant Enterococcus faecalis
by: Tiane Martin de Moura, et al.
Published: (2015-10-01) -
Vancomycin-resistant Enterococci: Epidemiology and Control
by: Yeşim ÇETİNKAYA
Published: (2000-03-01) -
Comparison of antibiotic resistance and virulence in vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains
by: Anna Sieńko, et al.
Published: (2018-12-01) -
The phenotypic and genotypic characterization of vancomycin-resistant enterococci in outpatients’ urine culture
by: Brkić Snežana, et al.
Published: (2017-01-01) -
Vancomycin Revisited - 60 years later
by: Ethan eRubinstein, et al.
Published: (2014-10-01)